Showing 37 to 48 of 75 results
Primorsky Cancer Patients Find Support in Volunteer Network
A meeting in Primorsky Krai connected cancer patients with 50 volunteers offering support, information, and resources; the initiative, supported by the regional health ministry, highlights peer-to-peer support and community involvement in cancer care.
Primorsky Cancer Patients Find Support in Volunteer Network
A meeting in Primorsky Krai connected cancer patients with 50 volunteers offering support, information, and resources; the initiative, supported by the regional health ministry, highlights peer-to-peer support and community involvement in cancer care.
Progress
48% Bias Score
Rostov Doctors Successfully Remove Large Kidney Tumor from Severely Obese Patient
A 55-year-old, 190kg Rostov resident with heart problems and advanced kidney cancer, underwent a three-stage treatment plan (embolization, hemoglobin stabilization, and surgery) resulting in complete tumor removal.
Rostov Doctors Successfully Remove Large Kidney Tumor from Severely Obese Patient
A 55-year-old, 190kg Rostov resident with heart problems and advanced kidney cancer, underwent a three-stage treatment plan (embolization, hemoglobin stabilization, and surgery) resulting in complete tumor removal.
Progress
48% Bias Score
Successful Trial of Animal-Assisted Therapy at Greek Oncology Hospital
A successful trial of Greece's first hospital-based Animal Assisted Therapy program at Metaxa Oncology Hospital saw therapy dog Olympus positively impact patients undergoing chemotherapy; the program aims to improve patient well-being through rigorous dog evaluations and training.
Successful Trial of Animal-Assisted Therapy at Greek Oncology Hospital
A successful trial of Greece's first hospital-based Animal Assisted Therapy program at Metaxa Oncology Hospital saw therapy dog Olympus positively impact patients undergoing chemotherapy; the program aims to improve patient well-being through rigorous dog evaluations and training.
Progress
40% Bias Score
AstraZeneca's $1 Billion Acquisition of EsoBiotec Expands Cancer Immunotherapy Portfolio
AstraZeneca, Britain's largest listed pharmaceutical company, acquired Belgian biotech EsoBiotec for $1 billion to expand its cancer immunotherapy portfolio, offering faster and more cost-effective treatments; this follows other recent acquisitions and positive drug development news.
AstraZeneca's $1 Billion Acquisition of EsoBiotec Expands Cancer Immunotherapy Portfolio
AstraZeneca, Britain's largest listed pharmaceutical company, acquired Belgian biotech EsoBiotec for $1 billion to expand its cancer immunotherapy portfolio, offering faster and more cost-effective treatments; this follows other recent acquisitions and positive drug development news.
Progress
40% Bias Score
Balancing efficiency and compassion in delivering difficult medical diagnoses
A doctor recounts delivering a critical cancer diagnosis over the phone due to a patient's delayed appointment and explores the ethical and logistical complexities of this decision.
Balancing efficiency and compassion in delivering difficult medical diagnoses
A doctor recounts delivering a critical cancer diagnosis over the phone due to a patient's delayed appointment and explores the ethical and logistical complexities of this decision.
Progress
60% Bias Score
Italy Addresses Critical Shortage of Anesthesiologists with Specialized Training
Italy launches a 9-month course to train 37 anesthesiologists specialized in oncology, addressing a nationwide shortage caused by low pay, high workload, and emigration of specialists, impacting patient care.
Italy Addresses Critical Shortage of Anesthesiologists with Specialized Training
Italy launches a 9-month course to train 37 anesthesiologists specialized in oncology, addressing a nationwide shortage caused by low pay, high workload, and emigration of specialists, impacting patient care.
Progress
24% Bias Score
Cancer Death Rates Decline in US, but Increases in Specific Cancers Remain
The National Cancer Institute's 2024 report shows a decline in overall cancer death rates (1.7% annually for men, 1.3% for women) between 2018 and 2022, attributed to improved screening, treatment, and reduced tobacco use; however, some cancers, like pancreatic and oral cavity cancers, saw increased...
Cancer Death Rates Decline in US, but Increases in Specific Cancers Remain
The National Cancer Institute's 2024 report shows a decline in overall cancer death rates (1.7% annually for men, 1.3% for women) between 2018 and 2022, attributed to improved screening, treatment, and reduced tobacco use; however, some cancers, like pancreatic and oral cavity cancers, saw increased...
Progress
48% Bias Score
Intracellular Galectin-1 in Pancreatic Cancer Stroma Drives Aggressiveness
An international study published in PNAS identifies Galectin-1 (Gal1) within the nuclei of pancreatic cancer stroma fibroblasts as a key driver of tumor aggressiveness, opening avenues for new therapeutic strategies targeting this protein's intracellular function to improve treatment response in thi...
Intracellular Galectin-1 in Pancreatic Cancer Stroma Drives Aggressiveness
An international study published in PNAS identifies Galectin-1 (Gal1) within the nuclei of pancreatic cancer stroma fibroblasts as a key driver of tumor aggressiveness, opening avenues for new therapeutic strategies targeting this protein's intracellular function to improve treatment response in thi...
Progress
20% Bias Score
NeuroSafe Prostate Surgery Improves Erectile Function Preservation
A UK trial of 344 men with prostate cancer shows NeuroSafe surgery nearly doubles the chances of preserving erectile function compared to standard surgery; one year later, 38% of the NeuroSafe group reported severe erectile dysfunction, versus 56% in the standard surgery group.
NeuroSafe Prostate Surgery Improves Erectile Function Preservation
A UK trial of 344 men with prostate cancer shows NeuroSafe surgery nearly doubles the chances of preserving erectile function compared to standard surgery; one year later, 38% of the NeuroSafe group reported severe erectile dysfunction, versus 56% in the standard surgery group.
Progress
40% Bias Score
BioNTech Restructures, Shifting Focus to mRNA Cancer Therapies
BioNTech, due to reduced Covid-19 vaccine demand, will cut 250-350 jobs in Marburg and up to 150 in Idar-Oberstein, but add 800-1200 positions elsewhere, focusing on mRNA cancer therapies with a goal of market approval by 2026.
BioNTech Restructures, Shifting Focus to mRNA Cancer Therapies
BioNTech, due to reduced Covid-19 vaccine demand, will cut 250-350 jobs in Marburg and up to 150 in Idar-Oberstein, but add 800-1200 positions elsewhere, focusing on mRNA cancer therapies with a goal of market approval by 2026.
Progress
40% Bias Score
Liquid Biopsies: Revolutionizing Cancer Treatment
Liquid biopsies, blood tests detecting tumor traces, are transforming cancer treatment by enabling earlier detection and personalized therapies; however, high costs and complex analysis limit widespread adoption in Spain, where their use is most advanced in lung, colon, and rectal cancers.
Liquid Biopsies: Revolutionizing Cancer Treatment
Liquid biopsies, blood tests detecting tumor traces, are transforming cancer treatment by enabling earlier detection and personalized therapies; however, high costs and complex analysis limit widespread adoption in Spain, where their use is most advanced in lung, colon, and rectal cancers.
Progress
28% Bias Score
mRNA Vaccine Shows Promise in Extending Survival for Early-Stage Pancreatic Cancer
A clinical trial at Memorial Sloan Kettering successfully used a customized mRNA vaccine alongside surgery and chemotherapy to treat early-stage pancreatic cancer, resulting in significantly extended survival time for eight of sixteen patients who showed strong immune responses and only two recurren...
mRNA Vaccine Shows Promise in Extending Survival for Early-Stage Pancreatic Cancer
A clinical trial at Memorial Sloan Kettering successfully used a customized mRNA vaccine alongside surgery and chemotherapy to treat early-stage pancreatic cancer, resulting in significantly extended survival time for eight of sixteen patients who showed strong immune responses and only two recurren...
Progress
40% Bias Score
Showing 37 to 48 of 75 results